BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Myriad Genetics, Inc. 

320 Wakara Way

Salt Lake City  Utah  84108  U.S.A.
Phone: 801-584-3600 Fax: 801-584-3640


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Pathway Genomics Corporation Responds To Myriad Genetics, Inc. (MYGN) Lawsuit, Defends The Rights Of All Women To Receive BRCA Testing Regardless Of Socioeconomic Status 6/16/2014 10:33:55 AM
Myriad Genetics, Inc. (MYGN) Announces Retirement Of James Evans, Chief Financial Officer 6/10/2014 9:25:47 AM
Myriad Genetics, Inc. (MYGN) To Present At The Goldman, Sachs & Co. Global Healthcare Conference 6/3/2014 9:15:02 AM
Myriad Genetics, Inc. (MYGN) myPath™Melanoma Test Improves The Reliability Of Melanoma Diagnosis 6/2/2014 9:34:02 AM
Myriad Genetics, Inc. (MYGN) Presents Clinical Data On Myriad Myrisk™ Hereditary Cancer Test At American Society of Clinical Oncology 6/2/2014 9:31:55 AM
Myriad Genetics, Inc. (MYGN) Announces Participation In Innovative Collaboration To Accelerate Hereditary Cancer Research 6/2/2014 9:05:48 AM
Myriad Genetics, Inc. (MYGN) Presents Data On Bracanalysis CDx™ And HRD™ At 2014 American Society of Clinical Oncology Meeting 5/30/2014 9:09:21 AM
Myriad Genetics, Inc. (MYGN) Release: Prolaris® Test Predicts Mortality Risk In Prostate Cancer Biopsy Study 5/20/2014 9:27:09 AM
Myriad Genetics, Inc. (MYGN) Strengthens Commitment To Cancer Research At The American Society of Clinical Oncology 50th Annual Meeting 5/15/2014 9:20:51 AM
Myriad Genetics, Inc. (MYGN) To Present At The Bank of America (BAC) 2014 Healthcare Conference 5/9/2014 9:30:11 AM
12345678910...